+1,639.4%
LRCX vs BBIO
+136.7%
+1,502.7%
-56.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.1% | -0.1% | +0.2% | +0.1% |
| 7D | -3.1% | -3.2% | +0.1% | -2.6% |
| 30D | -8.6% | -13.6% | +5.0% | -6.7% |
| 3M | -17.7% | +7.2% | -24.9% | -18.6% |
| 6M | +36.4% | +1.5% | +34.9% | +35.8% |
| YTD | +74.5% | -5.3% | +79.8% | +74.8% |
| 1Y | +159.4% | +37.7% | +121.7% | +146.2% |
| 3Y | +361.6% | +153.9% | +207.7% | +291.9% |
| 5Y | +425.2% | +43.9% | +381.4% | +287.6% |
| All | +1,639.4% | +136.7% | +1,502.7% | +959.6% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling